Suresh Mahabhashyam
Chief Tech/Sci/R&D Officer bei CORVUS PHARMACEUTICALS, INC.
Profil
Suresh Mahabhashyam is currently working as the Vice President-Clinical Development at Corvus Pharmaceuticals, Inc. He previously worked as the Senior Medical Director at Alexion Pharmaceuticals, Inc. from 2012 to 2015 and as the Vice President-Safety & Risk Management at Infinity Pharmaceuticals, Inc. from 2018 to 2019.
Dr. Mahabhashyam holds a graduate degree from the University of North Texas Health Science Center and a doctorate degree from Bangalore Medical College & Research Institute.
Aktive Positionen von Suresh Mahabhashyam
| Unternehmen | Position | Beginn |
|---|---|---|
| CORVUS PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 01.01.2020 |
Ehemalige bekannte Positionen von Suresh Mahabhashyam
| Unternehmen | Position | Ende |
|---|---|---|
| INFINITY PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01.01.2019 |
| ALEXION PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 01.01.2015 |
Ausbildung von Suresh Mahabhashyam
| University of North Texas Health Science Center | Graduate Degree |
| Bangalore Medical College & Research Institute | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| CORVUS PHARMACEUTICALS, INC. | Health Technology |
| INFINITY PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
